InvestorsHub Logo
Followers 13
Posts 1260
Boards Moderated 0
Alias Born 04/29/2011

Re: None

Monday, 10/05/2015 9:35:45 AM

Monday, October 05, 2015 9:35:45 AM

Post# of 625
GENFIT ANNOUNCES ELAFIBRANOR PRESENTATIONS
AND PRESIDENTIAL PLENARY AT THE 2015 AASLD
ANNUAL MEETING
? The results of the GOLDEN-505 phase 2b study of Elafibranor in
NASH have been selected for an exclusive oral presentation
during the Presidential Plenary session.
? Additional data from the Phase 2b study will be described in oral
presentations as well as in a poster session.


http://www.genfit.com/wp-content/uploads/2015/10/2015.10.02-PR-GENFIT-AASLD-2015.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ICPT News